Semin Reprod Med 2020; 38(02/03): 157-167
DOI: 10.1055/s-0040-1718921
Review Article

Current and Future Surgical and Interventional Management Options for Adenomyosis

Joseph Chen
1   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
,
Anne E. Porter
2   Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
,
Kimberly A. Kho
3   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
› Author Affiliations

Abstract

Historically, hysterectomy has been the recommended treatment for patients with adenomyosis. However, in the past two decades, various uterine-sparing treatment methods have emerged. These range from excisional techniques such as adenomyomectomy or wedge resection to uterine artery embolization, radiofrequency thermal ablation, hysteroscopic excision, endometrial ablation, and high-intensity focused ultrasound. While largely investigative for the treatment of adenomyosis, these procedures have demonstrated improvement in symptoms including abnormal uterine bleeding, dysmenorrhea, pelvic pain, and overall quality of life. However, long-term data including fertility and obstetric outcomes are needed. Future research is needed to better understand the impact of these uterine-preserving techniques to expand our armamentarium for the treatment of adenomyosis.



Publication History

Article published online:
05 November 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril 2010; 94 (04) 1223-1228
  • 2 Baekelandt J. Total vaginal NOTES hysterectomy: a new approach to hysterectomy. J Minim Invasive Gynecol 2015; 22 (06) 1088-1094
  • 3 Hyams LL. Adenomyosis; its conservative surgical treatment (hysteroplasty) in young women. N Y State J Med 1952; 52 (22) 2778-2784
  • 4 Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online 2011; 22 (01) 94-99
  • 5 Grimbizis GF, Mikos T, Zepiridis L. et al. Laparoscopic excision of uterine adenomyomas. Fertil Steril 2008; 89 (04) 953-961
  • 6 Fujishita A, Masuzaki H, Khan KN, Kitajima M, Ishimaru T. Modified reduction surgery for adenomyosis. A preliminary report of the transverse H incision technique. Gynecol Obstet Invest 2004; 57 (03) 132-138
  • 7 Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril 2018; 109 (03) 406-417
  • 8 Kwack JY, Im KS, Kwon YS. Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution. J Obstet Gynaecol Res 2018; 44 (07) 1268-1273
  • 9 Kwack JY, Kwon YS. Laparoscopic surgery for focal adenomyosis. JSLS 2017; 21 (02) 1-7
  • 10 Shim JI, Jo EH, Kim M. et al. A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy. Medicine (Baltimore) 2019; 98 (18) e15466
  • 11 Huang X, Huang Q, Chen S, Zhang J, Lin K, Zhang X. Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis. BMC Womens Health 2015; 15 (24) 24
  • 12 Kang L, Gong J, Cheng Z, Dai H, Liping H. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion. J Minim Invasive Gynecol 2009; 16 (02) 169-173
  • 13 Kwon YS, Roh HJ, Ahn JW, Lee SH, Im KS. Conservative adenomyomectomy with transient occlusion of uterine arteries for diffuse uterine adenomyosis. J Obstet Gynaecol Res 2015; 41 (06) 938-945
  • 14 Liu M, Cheng Z, Dai H, Qu X, Kang L. Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis. Eur J Obstet Gynecol Reprod Biol 2014; 176: 20-24
  • 15 Jun-Min X, Kun-Peng Z, Yin-Kai Z. et al. A new surgical method of U-shaped myometrial excavation and modified suture approach with uterus preservation for diffuse adenomyosis. BioMed Res Int 2018; 2018: 1657237
  • 16 Zhu L, Chen S, Che X, Xu P, Huang X, Zhang X. Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution. J Pain Res 2019; 12: 1917-1924
  • 17 Al Jama FE. Management of adenomyosis in subfertile women and pregnancy outcome. Oman Med J 2011; 26 (03) 178-181
  • 18 Mikos T, Lioupis M, Anthoulakis C, Grimbizis GF. The outcome of fertility-sparing and nonfertility-sparing surgery for the treatment of adenomyosis. a systematic review and meta-analysis. J Minim Invasive Gynecol 2020; 27 (02) 309-331.e3
  • 19 Chang WH, Wang KC, Lee NR. et al. Reproductive performance of severely symptomatic women with uterine adenomyoma who wanted preservation of the uterus and underwent combined surgical-medical treatment. Taiwan J Obstet Gynecol 2013; 52 (01) 39-45
  • 20 Xia W, Zhang D, Zhu Q. et al. Hysteroscopic excision of symptomatic myometrial adenomyosis: feasibility and effectiveness. BJOG 2017; 124 (10) 1615-1620
  • 21 Kohi MP, Spies JB. Updates on uterine artery embolization. Semin Intervent Radiol 2018; 35 (01) 48-55
  • 22 Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod 2010; 25 (05) 1177-1182
  • 23 Kim MD, Kim S, Kim NK. et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 2007; 188 (01) 176-181
  • 24 Kim MD, Won JW, Lee DY, Ahn CS. Uterine artery embolization for adenomyosis without fibroids. Clin Radiol 2004; 59 (06) 520-526
  • 25 Pelage JP, Jacob D, Fazel A. et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005; 234 (03) 948-953
  • 26 Froeling V, Scheurig-Muenkler C, Hamm B, Kroencke TJ. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment. Cardiovasc Intervent Radiol 2012; 35 (03) 523-529
  • 27 Zhou JHL, Duan H. et al. Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases. PLoS One 2016; 11 (11) e0165610
  • 28 Nijenhuis RJ, Smeets AJ, Morpurgo M. et al. Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire. Cardiovasc Intervent Radiol 2015; 38 (01) 65-71
  • 29 Liang E, Brown B, Rachinsky M. A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: results in 117 women. Aust N Z J Obstet Gynaecol 2018; 58 (04) 454-459
  • 30 Jha RC, Takahama J, Imaoka I. et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR Am J Roentgenol 2003; 181 (03) 851-856
  • 31 de Bruijn AM, Smink M, Hehenkamp WJK. et al. Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol Questionnaire. Cardiovasc Intervent Radiol 2017; 40 (09) 1344-1350
  • 32 Popovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol 2011; 22 (07) 901-909 , quiz 909
  • 33 Smeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HA, van Rooij WJ, Lohle PN. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol 2012; 35 (04) 815-819
  • 34 Kim MD, Kim NK, Kim HJ, Lee MH. Pregnancy following uterine artery embolization with polyvinyl alcohol particles for patients with uterine fibroid or adenomyosis. Cardiovasc Intervent Radiol 2005; 28 (05) 611-615
  • 35 Pisco JM, Duarte M, Bilhim T. et al. Spontaneous pregnancy with a live birth after conventional and partial uterine fibroid embolization. Radiology 2017; 285 (01) 302-310
  • 36 Cheung VYT. High-intensity focused ultrasound therapy. Best Pract Res Clin Obstet Gynaecol 2018; 46: 74-83
  • 37 Fukunishi H, Funaki K, Sawada K, Yamaguchi K, Maeda T, Kaji Y. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 2008; 15 (05) 571-579
  • 38 Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93 (01) 199-209
  • 39 Cheung VY. Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography 2017; 36 (02) 95-102
  • 40 So MJ, Fennessy FM, Zou KH. et al. Does the phase of menstrual cycle affect MR-guided focused ultrasound surgery of uterine leiomyomas?. Eur J Radiol 2006; 59 (02) 203-207
  • 41 Kim KA, Yoon SW, Lee C, Seong SJ, Yoon BS, Park H. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril 2011; 95 (03) 1152-1155
  • 42 Zhou M, Chen JY, Tang LD, Chen WZ, Wang ZB. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril 2011; 95 (03) 900-905
  • 43 Lee JS, Hong GY, Park BJ, Kim TE. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea. Ultrason Sonochem 2015; 27: 682-687
  • 44 Fan TY, Zhang L, Chen W. et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol 2012; 81 (11) 3624-3630
  • 45 Liu X, Wang W, Wang Y, Wang Y, Li Q, Tang J. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine (Baltimore) 2016; 95 (03) e2443
  • 46 Long L, Chen J, Xiong Y. et al. Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality. Int J Clin Exp Med 2015; 8 (07) 11701-11707
  • 47 Wang W, Wang Y, Tang J. Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis. Acad Radiol 2009; 16 (11) 1416-1423
  • 48 Polina L, Nyapathy V, Mishra A, Yellamanthili H, Vallabhaneni MP. Noninvasive treatment of focal adenomyosis with MR-guided focused ultrasound in two patients. Indian J Radiol Imaging 2012; 22 (02) 93-97
  • 49 Ferrari F, Arrigoni F, Miccoli A. et al. Effectiveness of magnetic resonance-guided focused ultrasound surgery (MRgFUS) in the uterine adenomyosis treatment: technical approach and MRI evaluation. Radiol Med (Torino) 2016; 121 (02) 153-161
  • 50 Shui L, Mao S, Wu Q. et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem 2015; 27: 677-681
  • 51 Guo Q, Xu F, Ding Z, Li P, Wang X, Gao B. High intensity focused ultrasound treatment of adenomyosis: a comparative study. Int J Hyperthermia 2018; 35 (01) 505-509
  • 52 Lee BB, Yu SP. Radiofrequency ablation of uterine fibroids: a review. Curr Obstet Gynecol Rep 2016; 5 (04) 318-324
  • 53 Bergamini V, Ghezzi F, Cromi A. et al. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol 2005; 192 (03) 768-773
  • 54 Scarperi S, Pontrelli G, Campana C. et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis. JSLS 2015; 19 (04) 1-6
  • 55 Hai N, Hou Q, Ding X, Dong X, Jin M. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis. Br J Radiol 2017; 90 (1069): 20160119
  • 56 Philip CA, Le Mitouard M, Maillet L. et al. Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month follow-up. Eur J Obstet Gynecol Reprod Biol 2018; 227: 46-51
  • 57 Garry R, Shelley-Jones D, Mooney P, Phillips G. Six hundred endometrial laser ablations. Obstet Gynecol 1995; 85 (01) 24-29
  • 58 McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998; 4 (04) 350-359
  • 59 Riley KA, Davies MF, Harkins GJ. Characteristics of patients undergoing hysterectomy for failed endometrial ablation. JSLS 2013; 17 (04) 503-507
  • 60 Tresserra F, Grases P, Ubeda A, Pascual MA, Grases PJ, Labastida R. Morphological changes in hysterectomies after endometrial ablation. Hum Reprod 1999; 14 (06) 1473-1477
  • 61 Yang W, Liu M, Liu L. et al. Uterine-sparing laparoscopic pelvic plexus ablation, uterine artery occlusion, and partial adenomyomectomy for adenomyosis. J Minim Invasive Gynecol 2017; 24 (06) 940-945
  • 62 Ai G, Ding L, Luo N, Cheng Z. The application of uterine artery occlusion combined with uterine-vaginal nerve block technique in patients with adenomyosis. Gynecol Minim Invasive Ther 2019; 8 (04) 194-195
  • 63 Wang CJ, Yen CF, Lee CL, Soong YK. Laparoscopic uterine artery ligation for treatment of symptomatic adenomyosis. J Am Assoc Gynecol Laparosc 2002; 9 (03) 293-296
  • 64 Hai N, Zhang J, Xu R, Han ZY, Liu FY. Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience. Int J Hyperthermia 2017; 33 (06) 646-652
  • 65 Yang Y, Zhang J, Han ZY. et al. Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function. Sci Rep 2015; 5: 10034